Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its price target increased by analysts at Mizuho from $197.00 to $201.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the financial services provider’s stock. Mizuho’s target price would suggest a potential upside of 13.86% from the company’s previous close.
Several other brokerages also recently commented on MRSH. Citigroup downgraded Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 target price on the stock. in a research note on Wednesday. Keefe, Bruyette & Woods boosted their price target on Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research note on Friday, April 17th. Weiss Ratings cut Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Barclays reduced their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Finally, UBS Group boosted their target price on Marsh & McLennan Companies from $203.00 to $212.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $201.69.
View Our Latest Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Stock Up 0.3%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.89 by $0.07. The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, analysts anticipate that Marsh & McLennan Companies will post 10.39 earnings per share for the current fiscal year.
Insider Activity
In other news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of MRSH. Solstein Capital LLC bought a new position in shares of Marsh & McLennan Companies in the 4th quarter worth approximately $25,000. Asset Dedication LLC bought a new stake in Marsh & McLennan Companies during the first quarter valued at approximately $25,000. SHP Wealth Management purchased a new stake in Marsh & McLennan Companies during the fourth quarter valued at approximately $26,000. KERR FINANCIAL PLANNING Corp bought a new position in Marsh & McLennan Companies in the fourth quarter worth approximately $27,000. Finally, Golden State Wealth Management LLC purchased a new position in shares of Marsh & McLennan Companies during the 4th quarter worth $27,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Articles
- Five stocks we like better than Marsh & McLennan Companies
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
